Global Cryoablation Systems Market 2017-2021
About Cryoablation Systems
The process of removing carcinogenic cells from the body by using refrigerant is known as cryoablation. This mechanism of action is used to treat direct cellular injuries and also microvascular injuries. Cryoablation systems are used in the treatment of epidermal, subcutaneous, and endometrial abnormalities by freezing the malignant cells. The advanced cryoablation system uses the argon gas for treating the malignancy in an individual.
Technavio’s analysts forecast the global cryoablation systems market to grow at a CAGR of 5.23% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cryoablation systems market for 2017-2021. To calculate the market size, the report considers the sales and volumes of cryoablation systems.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Cryoablation Systems Market 2017-2021
Technavio recognizes the following companies as the key players in the global cryoablation systems market: CooperSurgical, Galil Medical, and Medtronic.
Other Prominent Vendors in the market are: ACS Myanmar Medical, AtriCure, BVM Medical, Channel Medsystems, CPSI Biotech, ForTec Medical, HealthTronics, IRANBEHDASHT, ICECURE MEDICAL, METRUM CRYOFLEX, PENTAX Medical, Sanarus, and Solution Medical.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increased efficiency of cryoimmunotherapy. Immunotherapy with the help of cryoablation is a growing market trend, which can increase the adoption of cryoablation systems and thereby increase profits of manufacturers. Cryoimmunotherapy is considered to be an effective therapy for the diagnosis of malignant cells or tumors.”
According to the report, one driver in the market is preference for cryoablation over RF. Increased precision and accuracy of cryoablation devices has led to an increase in adoption worldwide. The surgeries performed using cryoablation devices are less invasive and lead to lesser complications compared with conventional resection procedures. Catheter cryoablation (CRYO) is regarded as one of the latest and most efficient approach for the treatment of cardiac arrhythmia over RF. The lesion to carry out the procedure with the help of cryoablation systems are well circumscribed with the requirement of minimal thrombus and preservation of the extracellular matrix.
Further, the report states that one challenge in the market is high cost of cryoablation procedures. The cost of cryosurgeries is high compared to the many tissue ablation procedures. AF treatment with the help of cryoablation system is expensive. The average Medicare reimbursement is $9,500 for uncomplicated AF ablation. According to a study conducted by Stony Brook University in 2016, the cost of cryoablation was high compared and RF ablation procedures. The 1276 patient suffering from cardiovascular disease and additional arrhythmias underwent cryoablation procedures. Sensitivity models showed higher costs in both Cryo sub-groups compared with RF.
CooperSurgical, Galil Medical, and Medtronic, ACS Myanmar Medical, AtriCure, BVM Medical, Channel Medsystems, CPSI Biotech, ForTec Medical, HealthTronics, IRANBEHDASHT, ICECURE MEDICAL, METRUM CRYOFLEX, PENTAX Medical, Sanarus, and Solution Medical.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook